0.03
+0.0056(+25.57%)
Currency In USD
Address
5251 Edina Industrial Boulevard
Minneapolis, MN 55439
United States of America
Phone
952 405 6216
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
20
First IPO Date
August 11, 2021
| Name | Title | Pay | Year Born |
| Mr. John Lai | Chief Executive Officer, President & Director | 195,579 | 1962 |
| Mr. John F. Dolan | General Counsel, Chief Business Development Officer & Secretary | 40,250 | 1965 |
| Mr. Michael Eldred BA, MBA | Commercialization & Operations Advisor and Executive Director | 42,080 | 1970 |
| Mr. Garry N. Lowenthal | Chief Financial Officer | 233,220 | 1959 |
| Ms. April Boyce | Vice President of Sales & Marketing | 0 | N/A |
PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Kush, a veterinarian-administered joint injection for the treatment of osteoarthritis and lameness in dogs and horses. The company's pipeline products include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Minneapolis, Minnesota.